SCHEMBL22947665

SCHEMBL22947665

c1ccc(-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4-c4ccc5c(c4)[Si](c4ccccc4)(c4cccc6ccccc46)c4ccccc4-5)n3)cc2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.36
ALDH1A1 P00352 3/20 0.36
HPGD P15428 3/20 0.36
TSHR P16473 2/20 0.36
KDM4E B2RXH2 2/20 0.36
ATM Q13315 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TP53 P04637 1/20 0.36
NFKB1 P19838 1/20 0.36
MAPK1 P28482 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
HSD17B10 Q99714 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MCL1 Q07820 1/20 0.32
ACMSD Q8TDX5 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
ALOX15 P16050 1/20 0.32
ADORA2A P29274 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22947720 0.99 MAPT (0.37) MAPTALDH1A1HPGDTSHRKDM4E
SCHEMBL22947656 0.95 MAPT (0.38) MAPTALDH1A1HPGDTSHRKDM4E
SCHEMBL22947667 0.94 MAPT (0.39) MAPTALDH1A1HPGDTSHRKDM4E
SCHEMBL22949381 0.94 MAPT (0.39) MAPTALDH1A1HPGDTSHRKDM4E
SCHEMBL22949691 0.94 MAPT (0.39) MAPTALDH1A1HPGDTSHRKDM4E
SCHEMBL22949123 0.94 ALDH1A1 (0.39) MAPTALDH1A1HPGDTSHRKDM4E
SCHEMBL22947598 0.93 MAPT (0.40) MAPTALDH1A1HPGDTSHRKDM4E
SCHEMBL22947481 0.90 MEN1 (0.36) MAPTALDH1A1HPGDTSHRKDM4E
SCHEMBL22949335 0.89 MAPT (0.40) MAPTALDH1A1HPGDTSHRKDM4E
SCHEMBL22947659 0.89 MAPT (0.40) MAPTALDH1A1HPGDTSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 MAPT 3103/4885ALDH1A1 752/4885HPGD 2601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.